In 1999 an information and prevention campaign was launched in Belgium to inform health professionals and the general public about the possible influence of medicines on driving abilities. This campaign was based on a scientific report containing literature data of 179 medicines with categorisation in 7 classes according to the impairing effects. The preliminary report was submitted to the concerned pharmaceutical companies to inform them of the initiative. This contribution describes the reactions of the co-ordinating association of the medicine industry and the individual companies.
Abstract